FindMyRecallSubscribe
Class I: serious health riskTerminated

Mylan Institutional Methotrexate Injection Recall

Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5…

Mylan Institutional LLC · Rockford, IL

Risk level
Class I
Reported by FDA
Aug 19, 2015
Recall ID
D-1328-2015
Check your lot numberHow we source this data

Summary

Mylan Institutional recalled Methotrexate Injection starting Mar 18, 2015. The FDA classified it as Class I (serious health risk) and published enforcement report D-1328-2015 on Aug 19, 2015. Reason: Presence of Particulate Matter. Status: Terminated.

Why it was recalled

Presence of Particulate Matter

Product description

Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per carton, Rx only, labeled as a) Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017, NDC 0069-0146-01; and b) Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-467-99.

Lot numbers, UPCs & expiration codes

Lot #: a) 7801082, Exp. 07/15 and b) 7801421, Exp. 09/16

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1328-2015
Classification
Class I
Status
Terminated
Recall initiated
Mar 18, 2015
FDA report date
Aug 19, 2015
Quantity
a) 15,095 vials b) 300 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan Institutional LLC

Original FDA data

Every field from FDA enforcement report D-1328-2015, exactly as published.

Show all FDA fields
City
Rockford
State
IL
Status
Terminated
Country
United States
Event ID
70936
Address
4901 Hiawatha Dr
Code information
Lot #: a) 7801082, Exp. 07/15 and b) 7801421, Exp. 09/16
Postal code
61103-1287
Report date
Aug 19, 2015
Product type
Drugs
Recall number
D-1328-2015
Classification
Class I
Recalling firm
Mylan Institutional LLC
Product quantity
a) 15,095 vials b) 300 vials
Termination date
Jun 29, 2016
Reason for recall
Presence of Particulate Matter
Voluntary / mandated
Voluntary: Firm initiated
Product description
Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per carton, Rx only, labeled as a) Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017, NDC 0069-0146-01; and b) Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-467-99.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Mar 18, 2015
Initial firm notification
Letter
Center classification date
Aug 13, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1328-2015, published Aug 19, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls